http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103352026-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 |
| filingDate | 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103352026-B |
| titleOfInvention | Human cord blood rich platelet lysate cultivates autologous umbilical cord mesenchymal stem cells method |
| abstract | The present invention relates to a kind of human cord blood rich platelet lysate and cultivate autologous umbilical cord mesenchymal stem cells method., therefore, in following clinical umbilical cord stem cells application, really can there is the residual risk of foreign protein in the processes such as current cell bank preparation process all uses calf or hyclone to carry out cultivating, digests, frozen.Present invention composition includes: the preparation of Cord blood rich platelet serum, the preparation of platelet lysates liquid, go the preparation of platelet serum, the cytokine PDGF AB, FGF2 in platelet lysates liquid, TGF β, the determination of VEGF content, the separation of umbilical cord stem cells and original cuiture, the cultivation of umbilical cord stem cells and passing on, umbilical cord stem cells is frozen, chromosome karyotype analysis.The present invention is used for culturing stem cells. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018158542-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4091618-A1 |
| priorityDate | 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.